Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![PATENTE_ES2881149B2 (1).pdf.jpg](/retrieve/f5f68d0e-b861-4c23-a78c-360c4c2e74c6/PATENTE_ES2881149B2%20%281%29.pdf.jpg) | 18-nov-2022 | Aparatos y métodos para el diagnóstico de cáncer colorrectal | JOVER, RODRIGO; ALUSTIZA FERNÁNDEZ, Miren; VIDAL MARTÍNEZ, Lorena; CANALS HERNÁNDEZ, Antonio | ![](/image/openAccess.png) |
![2022 Health care use.pdf.jpg](/retrieve/a789e69e-4db5-46dc-b066-a33a46efd1ee/2022%20Health%20care%20use.pdf.jpg) | 2022 | Healthcare use among people with
diabetes mellitus in Europe: a
population-based cross-sectional study | Fuentes-Merlos, Álvaro; Quesada-Rico, José Antonio; Reina, Raúl; Orozco-Beltrán, Domingo | ![](/image/openAccess.png) |
![Transcriptional regulation of chemokine network by biologic monotherapy.pdf.jpg](/retrieve/06ad097f-3e35-4f9f-8563-cce6bf12b3cf/Transcriptional%20regulation%20of%20chemokine%20network%20by%20biologic%20monotherapy.pdf.jpg) | 2022 | Transcriptional regulation of chemokine network by biologic monotherapy in ileum of patients with Crohn’s disease | Linares, Raquel; Gutiérrez, Ana; Márquez-Galera, Ángel; Caparrós, Esther; Aparicio, José R.; Madero, Lucía; Payá, Artemio; López-Atalaya, José P.; Francés, Rubén | ![](/image/openAccess.png) |
![14-JEP-2022 (1).pdf.jpg](/retrieve/4b21a635-9871-4d52-a83b-3a44e9ce39d5/14-JEP-2022%20%281%29.pdf.jpg) | nov-2022 | Fear for the future: Eco-anxiety and health implications, a systematic review | Ruiz-Boluda, Maria Inmaculada; Senent Valero, Marina; Casas-Escolano, Mariola; Matijasevich, Alicia; Pastor-Valero, Maria | ![](/image/closedAccess.png) |
![15-M.Preventiva-2022 (1).pdf.jpg](/retrieve/4950512b-9056-4b17-b695-5af50162bf5f/15-M.Preventiva-2022%20%281%29.pdf.jpg) | dic-2022 | Estudio de percepción de seguridad en pacientes
aislados y no aislados en un hospital de agudos y
análisis de concordancia con su identificación por los
profesionales | Jiménez-Pericás, F.; GEA VELAZQUEZ DE CASTRO, MARÍA TERESA; Pastor-Valero, Maria; Miralles-Bueno, Juan Jose; Esparcia Novoa, M.J; Aranaz Andrés, Jesús María | ![](/image/openAccess.png) |
![Psychometric properties of the Clarke questionnaire.pdf.jpg](/retrieve/ef196a10-8cdd-4349-a947-1ee538517d8e/Psychometric%20properties%20of%20the%20Clarke%20questionnaire.pdf.jpg) | 2022 | Psychometric properties of the Clarke
questionnaire for hypoglycemia awareness in the
Spanish population with type 2 diabetes | Orozco-Beltrán, Domingo; Moreno-Perez, Oscar; Quesada, Jose A.; Lecumberri-Pascual, Edurne; Ruiz-Quintero, Manuel A.; Pomares-Gomez, Francisco J.; Jodar-Gimeno, Esteban; Pardo-Ruiz, Carlos; Mascarell-Martínez, Isabel; Mirete-López, Rosa M.; Caride-Miana, Elena; Fernández-Giménez, Antonio; López-Pineda, Adriana; Nouni-García, Rauf; Carratala-Munuera, Concepcion; Cebrián-Cuenca, Ana M. | ![](/image/closedAccess.png) |
![Tramadol and Cycling Is It the End of a “Painful” Relationship. An Insight From 60,802 Doping-Control Samples From 2012 to 2020.pdf.jpg](/retrieve/12b44654-d1c6-485e-85ca-9094451d80f2/Tramadol%20and%20Cycling%20Is%20It%20the%20End%20of%20a%20%e2%80%9cPainful%e2%80%9d%20Relationship.%20An%20Insight%20From%2060%2c802%20Doping-Control%20Samples%20From%202012%20to%202020.pdf.jpg) | 5-dic-2022 | Tramadol and Cycling: Is It the End of a “Painful” Relationship?. An Insight From 60,802 Doping-Control Samples
From 2012 to 2020 | Zandonai, Thomas; Peiró, Ana; Covelli, Caterina; de la Torre, Xavier; Botré, Francesco | ![](/image/closedAccess.png) |
![Influence of substituents of Perylenebisimides on the surface energy and.pdf.jpg](/retrieve/c3f7ed65-c349-4c11-94c9-39b9050dc3c3/Influence%20of%20substituents%20of%20Perylenebisimides%20on%20the%20surface%20energy%20and.pdf.jpg) | 2022 | Influence of substituents of Perylenebisimides on the surface energy and wettability: A systematic structure–property relationship analysis | Pérez-Ojeda, M.Eugenia; Zink Lorre, Nathalie; Pla, Sara; Sastre-Santos, Ángela; Fernández Lázaro, Fernando; Hirsch, Andreas | ![](/image/closedAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg](/retrieve/442d251d-8781-4a09-b495-e3bbda10e4df/Long-term%20deprescription%20in%20chronic%20pain%20and%20opioid%20use%20disorder%20patients.%20Pharmacogenetic%20and%20sex%20differences.pdf.jpg) | 18-nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |